Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Phase III Data Showed Novartis Investigational Bronchodilator QAB149 Significantly Improved Lung Function In COPD Patients
The Novartis investigational bronchodilator QAB149 (indacaterol) met the primary efficacy endpoints of improved lung function compared to placebo at 12 weeks in three pivotal phase III studies in chronic obstructive pulmonary disease (COPD) patients. In secondary endpoints of these studies, QAB149 demonstrated clinically relevant lung function improvements within five minutes of the first dose, lasting for 24 hours in COPD patients.

$940,000 In Stimulus Funds Won By UTSA Biologists To Advance Research: 2 Studies Will Focus On Food Safety And Disease Prevention
San Antonio ò€¦ Robert Renthal, professor of biochemistry in the College of Sciences" Department of Biology at The University of Texas at San Antonio and JosÓ© Lopez-Ribot, professor of microbiology in UTSA"s Department of Biology and a member of the university"s South Texas Center for Emerging Infectious Diseases, have received a combined $940,000 in stimulus funding from the National Institutes of Health to further their research over the next two years.
News of the day
Fighting The Challenges Of Poverty
It is estimated that 1.4 billion people live in extreme poverty, on less than $2 a day. In 2000, 189 nations declared that they would "free all men, women, and children from the abject and dehumanizing conditions of extreme poverty". These nations signed up to Millennium Development Goals (MDGs) to combat poverty by 2015. To help meet these complex challenges and "make poverty history" more knowledge and evidence is needed. A launch event Wednesday 22nd July 2009 at the Department for International Development (DFID) marks a new phase of research collaboration between the Economic and Social Research Council (ESRC) and DFID which will provide more robust social science research to address poverty alleviation amongst the poorest countries and peoples of the world.
Mental Health

Howard County Pharmacy Owner Indicted For Health Care Fraud

A federal grand jury yesterday indicted Pamela Arrey, age 48, of Glenelg, Maryland, for health care fraud and aggravated identity theft, announced United States Attorney for the District of Maryland Rod J. Rosenstein. According to the 13 count indictment, Arrey owned and operated two pharmacies trading as the Medicine Shoppe, on Liberty Road and Reisterstown Road in Baltimore. From January 2003 to July 2008, Arrey allegedly claimed reimbursement from health care benefit programs for purported "refills" of prescriptions which patients had never requested and for which no prescription drugs were ever dispensed to customers. The indictment seeks forfeiture of property obtained by Arrey as a result of the scheme, including $350,000 and residential property located in Glenelg, Maryland. The indictment also alleges that Arrey used the identity of patients to carry out the health care fraud scheme. Arrey faces a maximum sentence of 10 years in prison for each of the 12 counts of health care fraud and a mandatory minimum of two years in prison consecutive to any other sentence for aggravated identity theft. No court appearance has been scheduled. An indictment is not a finding of guilt. An individual charged by indictment is presumed innocent unless and until proven guilty at some later criminal proceedings. United States Attorney Rod J. Rosenstein thanked the Department of Health and Human Services - Office of Inspector General and the Food and Drug Administration - Office of Criminal Investigations for their investigative work. Mr. Rosenstein commended Assistant United States Attorneys Sandra Wilkinson and Tonya Kelly Kowitz, who are prosecuting the case. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009